232 related articles for article (PubMed ID: 18051307)
1. Expression and purification of recombinant active prostate-specific antigen from Escherichia coli.
Jeong S; Lee SW
J Microbiol Biotechnol; 2007 May; 17(5):840-6. PubMed ID: 18051307
[TBL] [Abstract][Full Text] [Related]
2. [Procaryotic expression, purification and identification of recombinant human prostate-specific antigen].
Wang ZJ; Zhang W; Wu HF; Sui YG
Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1080-3. PubMed ID: 18284054
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
Chen Z; Chen H; Stamey TA
J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and characterization of deglycosylated human pro-prostate-specific antigen.
Bowman KK; Clark J; Yu L; Mortara K; Radika K; Wang J; Zhan H
Protein Expr Purif; 2000 Dec; 20(3):405-13. PubMed ID: 11087680
[TBL] [Abstract][Full Text] [Related]
5. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
Robert M; Gibbs BF; Jacobson E; Gagnon C
Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
[TBL] [Abstract][Full Text] [Related]
6. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2.
Kumar A; Mikolajczyk SD; Goel AS; Millar LS; Saedi MS
Cancer Res; 1997 Aug; 57(15):3111-4. PubMed ID: 9242434
[TBL] [Abstract][Full Text] [Related]
7. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
[TBL] [Abstract][Full Text] [Related]
8. A structural model for the prostate disease marker, human prostate-specific antigen.
Villoutreix BO; Getzoff ED; Griffin JH
Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
[TBL] [Abstract][Full Text] [Related]
9. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.
Michel S; Collomb-Clerc E; Geourjon C; Charrier JP; Passagot J; Courty Y; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2005; 18(3):225-35. PubMed ID: 15593306
[TBL] [Abstract][Full Text] [Related]
10. Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography.
Wu P; Stenman UH; Pakkala M; Närvänen A; Leinonen J
Prostate; 2004 Mar; 58(4):345-53. PubMed ID: 14968435
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human cytomegalovirus protease with a C-terminal (His)6 extension: purification, autocatalytic release of the mature enzyme, and biochemical characterization.
Tomasselli AG; Paddock DJ; Curry KA; Garlick RL; Leone JW; Lull JM; Mutchler VT; Baker CA; Cavey GS; Mathews WR; Shelly JA; Finzel BC; Baldwin ET; Wells PA; Tomich CS
Protein Expr Purif; 1998 Dec; 14(3):343-52. PubMed ID: 9882568
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and expression of an alternative hKLK3 transcript coding for a variant protein of prostate-specific antigen.
Heuzé N; Olayat S; Gutman N; Zani ML; Courty Y
Cancer Res; 1999 Jun; 59(12):2820-4. PubMed ID: 10383139
[TBL] [Abstract][Full Text] [Related]
13. Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase.
Takayama TK; McMullen BA; Nelson PS; Matsumura M; Fujikawa K
Biochemistry; 2001 Dec; 40(50):15341-8. PubMed ID: 11735417
[TBL] [Abstract][Full Text] [Related]
14. Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen.
Leinonen J; Wu P; Koivunen E; Närvänen A; Stenman UH
Scand J Clin Lab Invest Suppl; 2000; 233():59-64. PubMed ID: 11317943
[TBL] [Abstract][Full Text] [Related]
15. Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR.
Takayama TK; Carter CA; Deng T
Biochemistry; 2001 Feb; 40(6):1679-87. PubMed ID: 11327827
[TBL] [Abstract][Full Text] [Related]
16. A novel isoform of a kallikrein-like protease, TLSP/hippostasin, (PRSS20), is expressed in the human brain and prostate.
Mitsui S; Yamada T; Okui A; Kominami K; Uemura H; Yamaguchi N
Biochem Biophys Res Commun; 2000 May; 272(1):205-11. PubMed ID: 10872828
[TBL] [Abstract][Full Text] [Related]
17. Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing.
Denmeade SR; Lövgren J; Khan SR; Lilja H; Isaacs JT
Prostate; 2001 Jul; 48(2):122-6. PubMed ID: 11433422
[TBL] [Abstract][Full Text] [Related]
18. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
[TBL] [Abstract][Full Text] [Related]
19. Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer.
Pampalakis G; Scorilas A; Sotiropoulou G
Clin Biochem; 2008 May; 41(7-8):591-7. PubMed ID: 18222179
[TBL] [Abstract][Full Text] [Related]
20. Selection of RNA aptamers specific to active prostate-specific antigen.
Jeong S; Han SR; Lee YJ; Lee SW
Biotechnol Lett; 2010 Mar; 32(3):379-85. PubMed ID: 19943183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
